SCHEMBL25307682

SCHEMBL25307682

COc1ccccc1-c1cccnc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.53
ALDH1A1 P00352 3/20 0.53
HPGD P15428 1/20 0.53
HSD17B10 Q99714 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
BLM P54132 1/20 0.47
AGER Q15109 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PDE5A O76074 2/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31019107 1.00 KDM4E (0.53) KDM4EALDH1A1HPGDHSD17B10TDP1
SCHEMBL25307003 0.86 L3MBTL1 (0.53) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL287024 0.84 KDM4E (0.55) KDM4EALDH1A1CYP3A4MAPTALOX15
SCHEMBL28432444 0.84 ALDH1A1 (0.56) KDM4EALDH1A1HPGDHSD17B10TDP1
SCHEMBL20406112 0.83 POLB (0.46) ALDH1A1HSD17B10TDP1CYP3A4POLB
SCHEMBL2268684 0.83 KDM4E (0.53) KDM4EALDH1A1CYP3A4MAPTALOX15
Hydrochloric Acid SCHEMBL8882233 0.83 KDM4E (0.53) KDM4EALDH1A1CYP3A4MAPTALOX15
SCHEMBL28864411 0.83 ALDH1A1 (0.54) KDM4EALDH1A1HPGDPOLBCTSA
SCHEMBL28864414 0.82 CLCN2 (0.48) KDM4EALDH1A1HPGDHSD17B10TDP1
SCHEMBL20754976 0.81 HTR7 (0.42) ALDH1A1HPGDHSD17B10ALOX15PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250122221-A1 SIX-MEMBERED CYCLOTHIAZOLE COMPOUND AND USE THEREOF NANJING ZAIMING PHARMACEUTICAL CO., LTD. (CN) 2025-04-17 US disclosed
EP-4464709-A1 SIX-MEMBERED CYCLOTHIAZOLE COMPOUND AND USE THEREOF Nanjing Zaiming Pharmaceutical Co., Ltd. (CN) 2024-11-20 EP disclosed
WO-2023134739-A1 SIX-MEMBERED CYCLOTHIAZOLE COMPOUND AND USE THEREOF 南京再明医药有限公司 2023-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122221-A1 SIX-MEMBERED CYCLOTHIAZOLE COMPOUND AND USE THEREOF POLRMT, POLQ, POLH KDM4E 2890/4885ALDH1A1 1554/4885HPGD 1614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.